Quadrise Plc (LON:QED - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 4.58 ($0.06) and traded as low as GBX 4 ($0.05). Quadrise shares last traded at GBX 4.04 ($0.06), with a volume of 3,873,371 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Shore Capital restated a "house stock" rating on shares of Quadrise in a research note on Thursday, May 1st.
View Our Latest Stock Report on QED
Quadrise Stock Performance
The firm has a market capitalization of £84.22 million, a PE ratio of -23.78 and a beta of 1.83. The company's 50-day moving average price is GBX 4.43 and its 200-day moving average price is GBX 4.58.
Quadrise Company Profile
(
Get Free Report)
Quadrise is a global innovator and licensor of the disruptive heavy oil and synthetic biofuel technology that produces its proprietary MSAR® and bioMSAR™ fuels. Quadrise employs a team of energy and fuel experts with extensive experience in commercial emulsion fuels, downstream, marine and power utility applications at a global level.
Quadrise's shares have been listed on the London Stock Exchange's AIM market since 2006 AIM: QED.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Quadrise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quadrise wasn't on the list.
While Quadrise currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
